2024
|
Invention
|
Liquid protein formulations containing ionic liquids.
Concentrated, low-viscosity, low-volume li... |
|
Invention
|
Liquid protein formulations containing viscosity-lowering agents.
Concentrated, low-viscosity, l... |
2020
|
Invention
|
Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (emmc). Conce... |
|
Invention
|
Liquid protein formulations containing cyclic adenosine monophosphate (camp) or adenosine triphos... |
2018
|
Invention
|
Liquid protein formulations containing cimetidine. Concentrated, low-viscosity, low-volume liquid... |
|
Invention
|
Liquid protein formulations containing thiamine. Concentrated, low-viscosity, low-volume liquid p... |
|
Invention
|
Liquid protein formulations containing thiamine pyrophosphate (tpp). Concentrated, low-viscosity,... |
2017
|
Invention
|
Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (bim). Concent... |
2015
|
Invention
|
Polysaccharide and nucleic acid formulations containing viscosity-lowering agents. Concentrated, ... |
2014
|
Invention
|
Liquid protein formulations containing organophosphates. Concentrated, low-viscosity, low-volume ... |
|
Invention
|
Liquid protein formulations containing water soluble organic dyes. Concentrated, low-viscosity, l... |
|
Invention
|
Liquid protein formulations containing viscosity-lowering agents. Concentrated, low-viscosity, lo... |
|
Invention
|
Liquid protein formulations containing ionic liquids. Concentrated, low-viscosity, low-volume liq... |
|
Invention
|
Liquid pharmaceutical formulations for injection comprising yellow 5 or orange g and uses thereof... |
|
Invention
|
Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate... |
|
Invention
|
Liquid pharmaceutical formulations for injection comprising procaine and uses thereof. Concentrat... |
|
Invention
|
Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminoprop... |